Author:
Porru Manuela,Pompili Luca,Caruso Carla,Leonetti Carlo
Reference27 articles.
1. Rubin EH, Gilliland DG (2012) Drug development and clinical trials-the path to an approved cancer drug. Nat Rev Clin Oncol 9:215–222
2. Kirschbaum A, Geisse NC, Sister T J, Meyer LM (1950) Effect of certain folic acid antagonists on transplanted myeloid and lymphoid leukemias of the F strain of mice. Cancer Res 10(12):762–768
3. Hutchinson L, Kirk R (2011) High drug attrition rates–where are we going wrong? Nat Rev Clin Oncol 8(4):189–190. doi: 10.1038/nrclinonc.2011.34
4. Skrbo N, Tenstad E, Mælandsmo GM, Sørlie T, Andersen K (2015) From autonomy to community; new perspectives on tumorigenicity and therapy resistance. Cancer Treat Rev 41(10):809–813. doi: 10.1016/j.ctrv.2015.10.004 . Epub 2015 Oct 20
5. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献